Biotech Stocks Icon

Biotech Stocks

Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

Recent Biotech Stocks Articles

Why Is Telesis Bio (TBIO) Stock Up 29% Today?

Telesis Bio stock is heading higher on Friday with heavy trading of TBIO shares despite a lack of news from the company.

7 AI Penny Stocks to Double Your Money: February 2024

Risk-seeking investors would be hard-pressed to find better opportunities than those in AI penny stocks in early 2024.

3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024

With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year.

NVAX Stock Climbs as Novavax Settles Covid-19 Vaccine Dispute

Novavax stock is climbing higher on Thursday as investors in NVAX shares react to it reaching a $475 million settlement with Gavi.

Move Over Magnificent 7, Say Hello to the GRANOLAS

Dive into the compelling world of GRANOLAS stocks: Europe's elite players shaping the future of pharmaceuticals, tech, and consumer goods.

3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition

Now could be the time to start looking into these biotech stocks as there are imminent approvals on their clinical trials.

Exit Now! 3 Biotech Stocks to Sell in February 2024

These biotech stocks to sell represent incredibly risky bets, amidst the sector's volatility and looming economic unpredictability.

Why Is Emergent BioSolutions (EBS) Stock Up 70% Today?

Investors in Emergent Biosolutions and EBS stock certainly have a big catalyst to cheer today, as the company announced a new CEO.

Wall Street Favorites: 7 Growth Stocks With Strong Buy Ratings for February 2024

Certain stocks continue to be loved on Wall Street. Analysts remain enamored of companies that continue to register strong earnings growth and dominate the markets in which they compete.

Why Is Iovance Therapeutics (IOVA) Stock Up 35% Today?

With Iovance Therapeutics gaining FDA approval for its novel skin cancer therapeutic, IOVA stock is proving the bears wrong.

Dear OCGN Stock Fans, Mark Your Calendars for Feb. 21

Ocugen stock is rising higher on Tuesday as OCGN stock fans prepare for an event tomorrow that could be a positive catalyst for shares.

Stock Alert: 3 Market Giants on the Brink of Monumental Rallies

During stock market ups and downs, identifying the next big players breeding massive value growth potentials is similar to finding a pearl in a vast ice lake.

3 AI Powerhouses Predicted to Soar 500% in the Next Tech Boom

Discover how these AI powerhouses are leveraging AI in the IT consulting, application software, and biotech industries.

3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential

Biotech stocks, namely those involved with gene editing, have been explosive and could see higher highs with strong catalysts.

Analyst Upgrades: 3 Stocks Predicted to Soar In Q2 2024

Pounce on the electric surge of analyst upgrades, guiding you through market uncertainties with considerable aplomb.

Triple Threat: 3 Stocks to Buy for 3X Upside Potential

You want speculative stocks with upside potential up to 3X returns? I’m going to give them to you. But you have to accept the risk.…

From Zero to Hero: 7 Stock Losers That Could Turn Things Around in 2024

Stock turnarounds can happen when you least expect it. And with the opposite scenario imposing a rude awakening, it’s time to at least consider last…

3 Revolutionary Biotech Stocks Poised for 10X Surge

Discover three biotech stocks set to soar in a $3.08 trillion market, merging medical innovations with financial growth opportunities.

7 Blue-Chip Stocks to Pick Up While They’re Down

If you are an investor like me, you don't want to miss out on any opportunity to load up on blue-chip stocks to buy when…